{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T04:47:10Z","timestamp":1782103630353,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Clinical Research of Chen Jumei Foundation","award":["Z2025040110"],"award-info":[{"award-number":["Z2025040110"]}]},{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province of China","doi-asserted-by":"crossref","award":["PL2024H153"],"award-info":[{"award-number":["PL2024H153"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 52272273"],"award-info":[{"award-number":["No. 52272273"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10735-026-10829-9","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:46:16Z","timestamp":1778895976000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Study on the synergistic efficacy and mechanism of CD24 silencing combined with trastuzumab in HER2-positive breast cancer"],"prefix":"10.1007","volume":"57","author":[{"given":"Yi","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinglu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wubin","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenkun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,16]]},"reference":[{"key":"10829_CR3","doi-asserted-by":"publisher","first-page":"155550","DOI":"10.1016\/j.prp.2024.155550","volume":"262","author":"S Ahuja","year":"2024","unstructured":"Ahuja S, Khan Aa, Zaheer S (2024) Understanding the spectrum of HER2 status in breast cancer: from HER2 positive to ultra low HER2. Pathol Res Pract 262:155550. https:\/\/doi.org\/10.1016\/j.prp.2024.155550","journal-title":"Pathol Res Pract"},{"issue":"9","key":"10829_CR19","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1158\/2159-8290.CD-19-0292","volume":"9","author":"RK Amaravadi","year":"2019","unstructured":"Amaravadi RK, Kimmelman AC, Debnath J (2019) Targeting autophagy in cancer: recent advances and future directions. Cancer Discov 9(9):1167\u20131181. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-0292","journal-title":"Cancer Discov"},{"key":"10829_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41698-025-01209-9","volume":"10","author":"C Atallah Nm, Quinn","year":"2026","unstructured":"Atallah Nm, Quinn C, Rakha E (2026) HER2 expression in breast cancer: evidence gaps and challenges. npj Precis Oncol 10:6. https:\/\/doi.org\/10.1038\/s41698-025-01209-9","journal-title":"npj Precis Oncol"},{"key":"10829_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"10829_CR11","doi-asserted-by":"publisher","first-page":"e0224137","DOI":"10.1371\/journal.pone.0224137","volume":"14","author":"E Demidenko","year":"2019","unstructured":"Demidenko E, Miller T (2019) Statistical determination of synergy based on Bliss definition of drugs independence. PLoS ONE 14:e0224137. https:\/\/doi.org\/10.1371\/journal.pone.0224137","journal-title":"PLoS ONE"},{"key":"10829_CR17","doi-asserted-by":"publisher","first-page":"118513","DOI":"10.1016\/j.lfs.2020.118513","volume":"262","author":"S Fattahi","year":"2020","unstructured":"Fattahi S, Amjadi-moheb F, Tabaripour R, Ashrafi GH, Akhavan-Niaki H (2020) PI3K\/AKT\/mTOR signaling in gastric cancer: epigenetics and beyond. Life Sci 262:118513. https:\/\/doi.org\/10.1016\/j.lfs.2020.118513","journal-title":"Life Sci"},{"key":"10829_CR10","doi-asserted-by":"publisher","first-page":"216994","DOI":"10.1016\/j.canlet.2024.216994","volume":"594","author":"P Hong","year":"2024","unstructured":"Hong P, Xu T, Xu J, Chen W, Hu H, Chen J, Li L, Zheng C, Li B, Liu J, Dai W, Li E, Zhang F, Xu W (2024) CD24 promotes metastasis and chemoresistance by directly targeting Arf6-ERK pathway in esophageal squamous cell carcinoma. Cancer Lett 594:216994. https:\/\/doi.org\/10.1016\/j.canlet.2024.216994","journal-title":"Cancer Lett"},{"key":"10829_CR24","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/cas.12427","volume":"105","author":"M Hosonaga","year":"2014","unstructured":"Hosonaga M, Arima Y, Sugihara E, Kohno N, Saya H (2014) Expression of CD24 is associated with HER2 expression and supports HER2-Akt signaling in HER2-positive breast cancer cells. Cancer Sci 105:779\u2013787. https:\/\/doi.org\/10.1111\/cas.12427","journal-title":"Cancer Sci"},{"key":"10829_CR26","doi-asserted-by":"publisher","first-page":"17077","DOI":"10.1038\/s41598-021-96449-7","volume":"11","author":"T Huth Hw, Castro-Gomes","year":"2021","unstructured":"Huth Hw, Castro-Gomes T, de Am G, Ropert C (2021) Translocation of intracellular CD24 constitutes a triggering event for drug resistance in breast cancer. Sci Rep 11:17077. https:\/\/doi.org\/10.1038\/s41598-021-96449-7","journal-title":"Sci Rep"},{"key":"10829_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41420-024-01858-y","volume":"10","author":"Y Jang","year":"2024","unstructured":"Jang Y, Kang S, Han Hh K, Bg C Nh (2024) CD24 induced cellular quiescence-like state and chemoresistance in ovarian cancer cells via miR-130a\/301a-dependent CDK19 downregulation. Cell Death Discov 10:81. https:\/\/doi.org\/10.1038\/s41420-024-01858-y","journal-title":"Cell Death Discov"},{"issue":"3","key":"10829_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s13105-021-00811-2","volume":"77","author":"J Liu","year":"2021","unstructured":"Liu J, Wang C, Li J, Yu Y, Liu Y, Liu H, Peng Q, Guan X (2021) Autophagy blockage promotes the pyroptosis of ox-LDL-treated macrophages by modulating the p62\/Nrf2\/ARE axis. J Physiol Biochem 77(3):419\u2013429. https:\/\/doi.org\/10.1007\/s13105-021-00811-2","journal-title":"J Physiol Biochem"},{"key":"10829_CR8","doi-asserted-by":"publisher","first-page":"1665342","DOI":"10.3389\/fonc.2025.1665342","volume":"15","author":"X Liu","year":"2025","unstructured":"Liu X, Yu X, Hu Q, Zhang N, Zhang S, Liu Y, Jia J, Qiao X (2025) Hsp70 regulates CD24 expression and promotes metastasis and invasion of lung cancer via the MAPK\/ERK signaling pathway. Front Oncol 15:1665342. https:\/\/doi.org\/10.3389\/fonc.2025.1665342","journal-title":"Front Oncol"},{"issue":"6","key":"10829_CR16","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/s41419-018-0681-z","volume":"9","author":"S Lu","year":"2018","unstructured":"Lu S, Yao Y, Xu G (2018) CD24 regulates sorafenib resistance via activating autophagy in hepatocellular carcinoma. Cell Death Dis 9(6):646. https:\/\/doi.org\/10.1038\/s41419-018-0681-z","journal-title":"Cell Death Dis"},{"issue":"10","key":"10829_CR22","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1200\/OP.21.00172","volume":"17","author":"O Mart\u00ednez-s\u00e1ez","year":"2021","unstructured":"Mart\u00ednez-s\u00e1ez O, Prat A (2021) Current and future management of HER2-positive metastatic breast cancer. JCO Oncol Pract 17(10):594\u2013604. https:\/\/doi.org\/10.1200\/OP.21.00172","journal-title":"JCO Oncol Pract"},{"issue":"2","key":"10829_CR23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2174\/1566523220666200623170738","volume":"20","author":"YH Ni","year":"2020","unstructured":"Ni YH, Zhao X, Wang W (2020) CD24, a review of its role in tumor diagnosis, progression and therapy. Curr Gene Ther 20(2):109\u2013126. https:\/\/doi.org\/10.2174\/1566523220666200623170738","journal-title":"Curr Gene Ther"},{"issue":"16","key":"10829_CR18","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1007\/s40265-020-01394-w","volume":"80","author":"SE Nunnery","year":"2020","unstructured":"Nunnery SE, Mayer IA (2020) Targeting the PI3K\/AKT\/mTOR pathway in hormone-positive breast cancer. Drugs 80(16):1685\u20131697. https:\/\/doi.org\/10.1007\/s40265-020-01394-w","journal-title":"Drugs"},{"issue":"4","key":"10829_CR21","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/1873-3468.14280","volume":"596","author":"FC Stempels","year":"2022","unstructured":"Stempels FC, Janssens MH, Terbeest M, Mesman RJ, Revelo NH, Ioannidis M, van den Bogaart G (2022) Novel and conventional inhibitors of canonical autophagy differently affect LC3-associated phagocytosis. FEBS Lett 596(4):491\u2013509. https:\/\/doi.org\/10.1002\/1873-3468.14280","journal-title":"FEBS Lett"},{"issue":"2","key":"10829_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-022-00579-0","volume":"22","author":"SM Swain","year":"2023","unstructured":"Swain SM, Shastry M, Hamilton E (2023) Targeting HER2-positive breast cancer: advances and future directions. Nat Rev Drug Discov 22(2):101\u2013126. https:\/\/doi.org\/10.1038\/s41573-022-00579-0","journal-title":"Nat Rev Drug Discov"},{"key":"10829_CR6","doi-asserted-by":"publisher","first-page":"1334922","DOI":"10.3389\/fimmu.2023.1334922","volume":"14","author":"H Wang","year":"2023","unstructured":"Wang H, Shi P, Shi X, Lv Y, Xie H, Zhao H (2023) Surprising magic of CD24 beyond cancer. Front Immunol 14:1334922. https:\/\/doi.org\/10.3389\/fimmu.2023.1334922","journal-title":"Front Immunol"},{"key":"10829_CR27","doi-asserted-by":"publisher","first-page":"e012118","DOI":"10.1136\/jitc-2025-012118","volume":"13","author":"J Wang","year":"2025","unstructured":"Wang J, Li H, Liu Y, Xiao X, Li J, Jiang S, Wang J, Cheng Y, Song Z, Wu Y, Gu C, Chen S, Xiong J, Zhang H, Xiang Y, Liao X (2025) CD24 recruits tumor-associated neutrophils to promote the progression of hepatocellular carcinoma. J Immunother Cancer 13:e012118 https:\/\/doi.org\/10.1136\/jitc-2025-012118","journal-title":"J Immunother Cancer"},{"key":"10829_CR9","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s41401-024-01419-0","volume":"46","author":"J Wang","year":"2025","unstructured":"Wang J, Zhang Hm Z, Gh Z, Ll, Shi J, Dai Zt, Li Jp, Li X, Sun F, Wu Y, Chen Sy L, Hn L, Xh, Xiang Y (2025) STT3-mediated aberrant N-glycosylation of CD24 inhibits paclitaxel sensitivity in triple-negative breast cancer. Acta Pharmacol Sin 46:1097\u20131110. https:\/\/doi.org\/10.1038\/s41401-024-01419-0","journal-title":"Acta Pharmacol Sin"},{"issue":"14","key":"10829_CR13","doi-asserted-by":"publisher","first-page":"R671","DOI":"10.1016\/j.cub.2019.06.014","volume":"29","author":"T Wollert","year":"2019","unstructured":"Wollert T (2019) Autophagy. Curr Biol 29(14):R671\u2013R677. https:\/\/doi.org\/10.1016\/j.cub.2019.06.014","journal-title":"Curr Biol"},{"issue":"12","key":"10829_CR14","doi-asserted-by":"publisher","first-page":"100871","DOI":"10.1016\/j.tranon.2020.100871","volume":"13","author":"Q Xie","year":"2020","unstructured":"Xie Q, Liu Y, Li X (2020) The interaction mechanism between autophagy and apoptosis in colon cancer. Transl Oncol 13(12):100871. https:\/\/doi.org\/10.1016\/j.tranon.2020.100871","journal-title":"Transl Oncol"},{"key":"10829_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12943-023-01716-y","volume":"22","author":"F Xing","year":"2023","unstructured":"Xing F, Gao H, Chen G, Sun L, Sun J, Qiao X, Xue J, Liu C (2023) CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer. Mol Cancer 22:6. https:\/\/doi.org\/10.1186\/s12943-023-01716-y","journal-title":"Mol Cancer"},{"key":"10829_CR5","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s12964-023-01315-w","volume":"21","author":"Y Yang","year":"2023","unstructured":"Yang Y, Zhu G, Yang L, Yang Y (2023) Targeting CD24 as a novel immunotherapy for solid cancers. Cell Commun Signal 21:312. https:\/\/doi.org\/10.1186\/s12964-023-01315-w","journal-title":"Cell Commun Signal"},{"key":"10829_CR7","doi-asserted-by":"publisher","first-page":"1401528","DOI":"10.3389\/fimmu.2024.1401528","volume":"15","author":"K Zhao","year":"2024","unstructured":"Zhao K, Wu C, Li X, Niu M, Wu D, Cui X, Zhao H (2024) From mechanism to therapy: the journey of CD24 in cancer. Front Immunol 15:1401528. https:\/\/doi.org\/10.3389\/fimmu.2024.1401528","journal-title":"Front Immunol"},{"issue":"1","key":"10829_CR15","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3892\/mmr.2019.10288","volume":"20","author":"J Zhuo","year":"2019","unstructured":"Zhuo J, Wang X (2019) Combination of targeting CD24 and inhibiting autophagy suppresses the proliferation and enhances the apoptosis of colorectal cancer cells. Mol Med Rep 20(1):539\u2013548. https:\/\/doi.org\/10.3892\/mmr.2019.10288","journal-title":"Mol Med Rep"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10829-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-026-10829-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10829-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T03:48:56Z","timestamp":1782100136000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10735-026-10829-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10829"],"URL":"https:\/\/doi.org\/10.1007\/s10735-026-10829-9","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,16]]},"assertion":[{"value":"6 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Conflict of interest"}},{"value":"All animal experiments were performed in accordance with the Guide for the Care and Use of Laboratory Animals, and all studies involving human breast cancer specimens were approved by the Ethics Committee of the Sixth Affiliated Hospital of Harbin Medical University (Ethics Approval No.: LC2024-138). Written informed consent was obtained from all participants or their legal representatives.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"168"}}